Bilateral refractory pneumothorax treated by pleurodesis and bronchial occlusion in a COVID-19 patient

Satoshi Tanaka; Yoshihiro Takayama; Riiko Kitou; Ryo Asakawa; Satoshi Tobita; Akihiro Ike; Masahiro Kawada; Suguru Yamamoto; Kiyonobu Ueno

doi:10.22541/au.166782068.80314548/v1

loading page

Bilateral refractory pneumothorax treated by pleurodesis and bronchial occlusion in a COVID-19 patient

Satoshi Tanaka,
Yoshihiro Takayama,
Riiko Kitou,
Ryo Asakawa,
Satoshi Tobita,
Akihiro Ike,
Masahiro Kawada,
Suguru Yamamoto,
Kiyonobu Ueno

Abstract

Coronavirus disease 2019 (COVID-19) can cause various complications. Pneumothorax secondary to COVID-19 is relatively uncommon and bilateral pneumothorax is even more so. In patients with poor general health to undergo surgery for pneumothorax, internal treatments are essential to relieving refractory pneumothorax.

05 Nov 2022Submitted to Clinical Case Reports

Show details

Hide details

07 Nov 2022Submission Checks Completed

07 Nov 2022Assigned to Editor

13 Nov 2022Reviewer(s) Assigned

22 Nov 2022Review(s) Completed, Editorial Evaluation Pending

22 Nov 2022Editorial Decision: Revise Minor

28 Nov 20221st Revision Received

03 Dec 2022Submission Checks Completed

03 Dec 2022Assigned to Editor

03 Dec 2022Review(s) Completed, Editorial Evaluation Pending

03 Dec 2022Editorial Decision: Accept

Dec 2022Published in Clinical Case Reports volume 10 issue 12. 10.1002/ccr3.6754

Abstract

Peer review status:Published